Department of Intensive Care, Leiden University Medical Centre, Leiden, the Netherlands; Department of Anesthesiology, Leiden University Medical Centre, Leiden, the Netherlands.
Department of Intensive Care, Leiden University Medical Centre, Leiden, the Netherlands; Department of Anesthesiology, Leiden University Medical Centre, Leiden, the Netherlands.
J Crit Care. 2022 Dec;72:154151. doi: 10.1016/j.jcrc.2022.154151. Epub 2022 Sep 28.
Oxygen therapy is vital in adult intensive care unit (ICU) patients, but it is indistinct whether higher or lower oxygen targets are favorable. Our aim was to update the findings of randomized controlled trials (RTCs) comparing higher and lower oxygen strategies.
MEDLINE, EMBASE, and Web of Science were searched. RCTs comparing higher (liberal, hyperoxia) and lower (conservative, normoxia) oxygen in adult mechanically ventilated ICU patients were included. The main outcome was 90-day mortality; other outcomes include serious adverse events (SAE), support free days and length of stay (LOS).
No significant difference was observed for 90-day mortality. A lower incidence was found for SAEs, favoring lower oxygenation (OR, 0.86; 95%CI, 0.77-0.96; I 13%). No differences were observed in either support free days at day 28 or ICU and hospital LOS.
No difference was found for 90-day mortality, support free days and ICU and hospital LOS. However, a lower incidence of SAEs was found for lower oxygenation. These findings may have clinical implications for practice guidelines, yet it remains of paramount importance to continue conducting clinical trials, comparing groups with a clinically relevant contrast and focusing on the impact of important side effects.
氧气疗法对成人重症监护病房(ICU)患者至关重要,但尚不清楚较高或较低的氧目标更有利。我们的目的是更新比较较高和较低氧策略的随机对照试验(RTC)的结果。
检索 MEDLINE、EMBASE 和 Web of Science。纳入了比较机械通气的成年 ICU 患者较高(宽松、高氧)和较低(保守、正常氧)氧的 RCT。主要结局为 90 天死亡率;其他结局包括严重不良事件(SAE)、无支持天数和住院时间(LOS)。
90 天死亡率无显著差异。较低的氧合组 SAE 发生率较低(OR,0.86;95%CI,0.77-0.96;I 2 =13%)。28 天时无支持天数或 ICU 和住院 LOS 无差异。
90 天死亡率、无支持天数和 ICU 及住院 LOS 无差异。然而,较低的氧合组 SAE 发生率较低。这些发现可能对实践指南具有临床意义,但继续进行临床试验、比较具有临床相关差异的组和关注重要副作用的影响仍然至关重要。